HIV self-testing remains underutilized among not only the general public, but especially people who use drugs.

The health clinic where Alice Okwirry collects her HIV medication in Kenya's capital Nairobi has been rationing supplies of ...

Researchers here described how they were able to safely and ethically enroll adolescents in a landmark trial of a drug that ...

Lenacapavir, which stops HIV from replicating inside cells, has passed early safety tests.

UCSF researchers are the first to confirm that this approach is effective for the patients who need it most. Patients who ...

Gilead's CROI 2025 data highlights Biktarvy's sustained HIV/HBV suppression, lenacapavir's efficacy, and vesatolimod's safety ...

SAN FRANCISCO -- At least 400 researchers, physicians, activists, and other concerned citizens gathered here Monday night to ...

Researchers from the HIV Prevention Trials Network (HPTN) have presented results from the HPTN 094 ("INTEGRA") study at the ...

Offering mailed self-testing for HIV encouraged patients to test themselves for HIV but require methods of improving ...

In the general population, frailty is an aging-related risk factor for poor outcomes; individuals experiencing frailty face ...

Adults living with HIV in Malawi are more than twice as likely to also have dementia compared to those without HIV, according ...

A team of pharmaceutical researchers at biopharma company Gilead Sciences has announced that a reformulation of its HIV ...